SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology to Address Company-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI'AN, CHINA, December 9 , 2009 — Skystar Bio-Pharmaceutical Company Skystar will manufacture its aquaculture vaccine in its new 51,000]

By | 2016-03-01T06:48:31+00:00 December 9th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and

[Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology to Address Company-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI'AN, CHINA, December 9 , 2009 — Skystar Bio-Pharmaceutical Company Skystar will manufacture its aquaculture vaccine in its new 51,000]

By | 2016-03-01T06:49:25+00:00 December 9th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology todressmpany-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI'AN, CHINA, December 9 , 2009ystar Bio-Pharmaceuticalmpanyystar will manufacture its aquaculture vaccine in its new 51,000 square]

By | 2016-02-05T04:45:37+00:00 December 9th, 2009|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and

[Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology todressmpany-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI'AN, CHINA, December 9 , 2009ystar Bio-Pharmaceuticalmpanyystar will manufacture its aquaculture vaccine in its new 51,000 square]

By | 2016-02-05T04:46:32+00:00 December 9th, 2009|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar